Senior Director, Head of APAC Markets, International Market Access at Bristol-Myers Squibb

Singapore, Singapore, Singapore

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ability to serve as a strategic partner to the SVP, APAC Markets
Capability to ensure alignment with the broader International Markets team and Global Market Access
Suitability for site-essential, site-by-design, field-based, or remote-by-design occupancy structure based on role nature (e.g., 100% onsite for site-essential, at least 50% onsite for site-by-design, ability to travel for field-based/remote roles)
Full Covid-19 vaccination and up-to-date boosters strongly recommended

Responsibilities

Serve as a strategic partner to the SVP, APAC Markets
Ensure alignment with the broader International Markets team and Global Market Access
Conduct work according to assigned occupancy structure (e.g., onsite presence, travel to customers/patients/business partners, attend meetings on behalf of BMS)

Skills

Market Access

Strategic Planning

APAC Markets

Leadership

Pharmaceuticals

Global Strategy

Commercial Strategy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free